# Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents

> **NCT01689324** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 43 (actual)

## Conditions studied

- Pertussis
- Tetanus
- Diphtheria

## Interventions

- **BIOLOGICAL:** (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

## Key facts

- **NCT ID:** NCT01689324
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-11
- **Final completion:** 2013-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01689324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01689324, "Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01689324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*